FGF23 and klotho at the intersection of kidney and cardiovascular disease

Daniel Edmonston1,2, Alexander Grabner1, Myles Wolf3,4

  • 1Division of Nephrology, Department of Medicine, Duke University School of Medicine, Durham, NC, USA.

PubMed

Insights

Cardiovascular disease is a major risk in chronic kidney disease (CKD). In CKD, fibroblast growth factor 23 (FGF23) and low klotho contribute to heart problems, necessitating holistic treatment of mineral imbalances.

Area of Science:

  • Nephrology
  • Cardiology
  • Endocrinology

Background:

  • Cardiovascular disease (CVD) is the primary cause of mortality in chronic kidney disease (CKD) patients.
  • CKD progression exacerbates CVD risk through CKD-specific factors like disordered mineral homeostasis.
  • Fibroblast growth factor 23 (FGF23) and klotho are key regulators of mineral balance, impacting cardiovascular health.

Purpose of the Study:

  • To explore the role of FGF23 and klotho in cardiovascular complications of CKD.
  • To investigate the mechanisms by which FGF23 excess and klotho deficiency promote cardiac dysfunction.
  • To evaluate the potential of targeting mineral homeostasis for improving cardiovascular outcomes in CKD.

Main Methods:

  • Review of emerging data on FGF23 and klotho in CKD-associated cardiovascular disease.
  • Analysis of the interplay between FGF23, klotho, and mineral metabolism.
  • Discussion of the clinical implications for managing cardiovascular risk in CKD.

Main Results:

  • Rising FGF23 and declining klotho in CKD lead to klotho-independent, detrimental cardiac effects, including left ventricular hypertrophy and heart failure.
  • Soluble klotho may offer protective cardiovascular benefits through various mechanisms.
  • The complex feedback loops between FGF23 and klotho make it challenging to isolate the primary driver of pathology.

Conclusions:

  • Targeting disordered mineral homeostasis holistically is crucial for improving cardiovascular outcomes in CKD patients.
  • Randomized trials should focus on practical interventions addressing mineral imbalances.
  • Further research is needed to fully elucidate the specific roles of FGF23 and klotho in distinct cardiovascular complications of CKD.

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
35
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage kidney disease (ESKD). At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate...
41
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
43
Physiology of the Genitourinary System I: Renal Blood Flow and Glomerular Filtration01:29

Physiology of the Genitourinary System I: Renal Blood Flow and Glomerular Filtration

The kidneys are vital organs responsible for regulating blood filtration, waste excretion, and fluid balance, all of which are crucial for maintaining homeostasis. Renal physiology examines renal blood flow, glomerular filtration, and urine formation, ensuring the body’s internal environment remains stable.Renal Blood FlowThe kidneys receive about 20-25% of the cardiac output, typically around 1200 mL of blood per minute in an average adult. Blood flows into the kidneys through the renal...
39
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
34
Glomerular Filtration Rate and its Regulation01:28

Glomerular Filtration Rate and its Regulation

The Glomerular Filtration Rate (GFR) is a measure of kidney function, reflecting the volume of filtrate formed per minute in the kidneys. On average, GFR is approximately 125 mL/min in males and 105 mL/min in females. Maintaining a relatively constant GFR is essential for the kidneys to effectively regulate body fluid homeostasis and maintain extracellular stability.
GFR regulation involves two primary intrinsic controls: the myogenic and tubuloglomerular feedback mechanisms.
The myogenic...
3.0K